ACM
GOSS icon

ADAR1 Capital Management’s Gossamer Bio GOSS Stock Holding History

ADAR1 Capital Management’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-5,790
Closed -$1.44M – 322
2025
Q4 		$1.44M Buy
+5,790
New +$1.32M 0.11% 116

Other funds holding GOSS

D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
DeepCurrents Investment Group
DeepCurrents Investment Group New York $3.3B AUM 12.57% 1-Year Est. Return
Context Capital Management
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
Wolverine Asset Management
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM

ADAR1 Capital Management's GOSS Position: Q2 2026 in Review

ADAR1 Capital Management reduced its Gossamer Bio (GOSS) stake by 26% in Q2 2026, selling an estimated $20.9K and leaving 2,657 shares worth $35K. The position accounts for ﹤0.01% of the portfolio, ranked #272.

ADAR1 Capital Management first reported a position in GOSS in Q4 2023 and has held it in 11 quarters since. The position peaked at $865K in Q1 2024. 166 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

  • ADAR1 Capital Management held 2,657 shares of Gossamer Bio worth $35K as of Q2 2026.
  • ADAR1 Capital Management sold 937 Gossamer Bio shares in Q2 2026, an estimated $20.9K.
  • Gossamer Bio made up ﹤0.01% of ADAR1 Capital Management's portfolio in Q2 2026, its #272 holding.
  • ADAR1 Capital Management first reported a position in Gossamer Bio in Q4 2023 and has held it in 11 quarters since.
  • ADAR1 Capital Management's Gossamer Bio position peaked at $865K in Q1 2024.
  • 166 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on ADAR1 Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.